Range Cancer Therapeutics ETF Rating → Does this make you sick? (From Allegiance Gold) (Ad) Free CNCR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share RatingsStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial MediaStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial Media Range Cancer Therapeutics ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CNCR Aggregate RatingModerate Buy2.73Holdings in CNCR have an aggregate rating of Moderate Buy based on 370 analyst ratings issued in the past year covering 50 companies (73.0% of the portfolio).CNCR Aggregate Price Target$31.53112.17% UpsideHigh Prediction$43.27Average Prediction$31.53Low Prediction$20.96Holdings in CNCR have an aggregate price target of $31.53 and a range of $20.96 to $43.27 covering 50 companies (73.0% of the portfolio).CNCR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Range Cancer Therapeutics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 CNCR Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.05%GERNGeron$3.80-2.1%4 of 5 stars2.80$6.10 60.5%5Gap Down2.27%IBRXImmunityBio$8.12+0.7%0 of 5 stars2.00$6.00 -26.1%1Gap Down2.17%CGEMCullinan Oncology$26.57-2.2%3 of 5 stars3.00$31.00 16.7%7Insider SellingShort Interest ↑2.12%ACRVAcrivon Therapeutics$8.77+7.7%4 of 5 stars2.88$22.63 158.0%8Upcoming EarningsPositive News2.08%DCPHDeciphera Pharmaceuticals$25.360.0%3 of 5 stars2.30$24.17 -4.7%10News Coverage2.05%ELVNEnliven Therapeutics$23.43-2.0%2 of 5 stars3.00$34.00 45.1%1Insider Selling2.01%JANXJanux Therapeutics$48.92-5.8%3 of 5 stars3.00$64.83 32.5%7Analyst ForecastAnalyst RevisionNews Coverage1.91%NUVBNuvation Bio$3.25-2.4%3 of 5 stars3.00$6.60 103.1%5Upcoming Earnings1.63%DAWNDay One Biopharmaceuticals$16.00-2.3%3 of 5 stars2.86$37.67 135.4%7Analyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.59%RVMDRevolution Medicines$37.25-0.5%4 of 5 stars3.10$41.60 11.7%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.52%TSVT2seventy bio$4.38-1.1%2 of 5 stars2.44$12.86 193.5%9Analyst ForecastAnalyst RevisionNews Coverage1.46%HCMHUTCHMED$21.75+4.5%2 of 5 stars2.75$29.70 36.6%4Short Interest ↓News CoverageGap UpHigh Trading Volume1.44%ITOSiTeos Therapeutics$17.44+43.1%2 of 5 stars3.00$30.33 73.9%3News CoverageGap UpHigh Trading Volume1.44%AGENAgenus$10.49-10.5%4 of 5 stars3.00$70.00 567.3%3Analyst ForecastShort Interest ↑Analyst RevisionGap Up1.44%YMABY-mAbs Therapeutics$12.28-4.6%2 of 5 stars2.33$16.57 34.9%6Analyst RevisionNews Coverage1.42%XNCRXencor$22.48-4.5%4 of 5 stars2.89$36.25 61.3%9Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.41%BPMCBlueprint Medicines$106.70-1.5%1 of 5 stars2.50$100.31 -6.0%16Short Interest ↑Analyst Revision1.40%MRKMerck & Co., Inc.$130.06-0.1%5 of 5 stars2.58$131.33 1.0%121.38%LYELLyell Immunopharma$2.46-8.2%1 of 5 stars2.50$5.50 123.6%2Analyst ForecastShort Interest ↑Gap Down1.38%MRUSMerus$44.52-1.3%2 of 5 stars3.00$56.33 26.5%11Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.38%BCYCBicycle Therapeutics$22.89-2.9%2 of 5 stars2.86$46.86 104.7%7Short Interest ↓1.35%TYRATyra Biosciences$17.35-2.3%2 of 5 stars2.67$22.00 26.8%3Analyst ForecastAnalyst RevisionNews CoverageGap Up1.34%AURAAura Biosciences$7.31-3.1%1 of 5 stars3.00$21.00 187.3%3Short Interest ↑News Coverage1.32%IPHAInnate Pharma$2.53+0.8%2 of 5 stars3.00$9.75 285.4%1Negative NewsGap Down1.31%ERASErasca$1.85-5.6%1 of 5 stars2.80$7.83 323.4%5Earnings ReportAnalyst ForecastNews Coverage1.29%SMMTSummit Therapeutics$4.65-2.7%1 of 5 stars3.00$7.50 61.3%2Analyst Forecast1.28%SDGRSchrödinger$22.73-1.8%3 of 5 stars2.67$42.80 88.3%91.28%IMCRImmunocore$58.95-1.5%2 of 5 stars2.87$82.00 39.1%15Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.28%PGENPrecigen$1.27-1.6%4 of 5 stars2.33$10.00 687.4%3Upcoming EarningsNews Coverage1.28%MORMorphoSys$18.00+0.7%1 of 5 stars2.38$11.78 -34.6%8Short Interest ↓1.28%INBXInhibrx$34.29-1.2%2 of 5 stars2.00$27.00 -21.3%2Upcoming EarningsNews Coverage1.27%GLUEMonte Rosa Therapeutics$4.85-6.4%2 of 5 stars2.67$11.00 126.8%3News Coverage1.27%MGNXMacroGenics$3.31-77.4%4 of 5 stars2.60$14.78 346.5%10Earnings ReportAnalyst DowngradeNews CoverageGap DownHigh Trading Volume1.27%BNTXBioNTech$91.67-0.4%2 of 5 stars2.27$118.82 29.6%11Analyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.27%FHTXFoghorn Therapeutics$5.56-6.4%1 of 5 stars2.67$14.50 160.8%3Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageHigh Trading Volume1.27%EXELExelixis$21.37-1.8%5 of 5 stars2.63$26.33 23.2%16Short Interest ↑1.27%SNDXSyndax Pharmaceuticals$21.75-1.0%3 of 5 stars2.91$34.42 58.2%11Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.27%RAPTRAPT Therapeutics$4.33-7.1%4 of 5 stars2.38$24.67 469.7%13Analyst DowngradeNews CoverageGap DownHigh Trading Volume1.25%VORVor Biopharma$1.71-5.5%3 of 5 stars3.00$13.50 689.5%5Analyst ForecastAnalyst RevisionNews CoverageGap Down1.24%GMABGenmab A/S$28.84+0.1%3 of 5 stars2.38$48.50 68.2%13Positive News1.24%REGNRegeneron Pharmaceuticals$973.80+0.6%4 of 5 stars2.70$981.71 0.8%20Positive News1.24%SWTXSpringWorks Therapeutics$40.89-4.8%2 of 5 stars3.00$68.83 68.3%6Analyst Revision1.22%STROSutro Biopharma$4.15-4.6%5 of 5 stars3.00$12.50 201.2%8Analyst ForecastNews Coverage1.22%NRIXNurix Therapeutics$13.51-3.2%2 of 5 stars2.83$21.33 57.9%61.21%KURAKura Oncology$20.71-0.3%3 of 5 stars2.88$28.28 36.5%81.21%IGMSIGM Biosciences$9.34-7.7%4 of 5 stars2.50$17.89 91.5%8Analyst ForecastShort Interest ↑News Coverage1.20%IDYAIDEAYA Biosciences$41.17+1.3%3 of 5 stars3.00$47.50 15.4%12Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.20%KYMRKymera Therapeutics$37.90-1.8%0 of 5 stars2.50$41.10 8.4%121.18%IMTXImmatics$10.83+1.8%0 of 5 stars3.001News CoverageHigh Trading Volume1.15%IOVAIovance Biotherapeutics$10.97-18.4%5 of 5 stars3.00$24.64 124.7%10Earnings ReportAnalyst ForecastNews CoverageGap DownHigh Trading Volume This page (NASDAQ:CNCR) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressElon to Transform U.S. Economy? Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
